The seal was given to the over-the-counter pain reliever by the ADA Council on Scientific Affairs based on its ability to temporarily manage acute dental pain, according to a Sept. 23 news release.
The new category is titled “orally administered analgesic for the temporary management of acute dental pain” and supports clinical practice guidelines from the ADA that recommend using nonsteroidal anti-inflammatory drugs by themself or in combination with acetaminophen to help ease short-term dental pains.
The ADA’s seal of acceptance program was created in 1931 to help dental professionals make recommendations to patients about consumer products. Currently, there are more than 400 products that have the ADA’s seal, the release said.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place November 12–14 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
